NASDAQ: MRNA - Moderna

Yield per half year: +14.64%
Sector: Healthcare

Share chart Moderna


About

Moderna — американская биотехнологическая компания, занимающаяся исследованием и разработкой лекарств на основе исключительно РНК-мессенджера.

В основе компании идея с mRNA — мессенджер РНК. Искуственно создается возбудитель вируса и создается препарат, который тренирует иммунную систему. Надо только расшифровать геном вируса, загрузить в комп, и на выходе будет состав вакцины. И так практически с любым вирусом. Проблема с доставкой этого мРНК в клетки человека. У Модерны 21 разработка, 10 проходят клинические испытания и НОЛЬ одобренных препаратов.


Цена ао 122.45
P/S 130.09
P/BV 5.32
EV/EBITDA -11.94
EBITDA -0.5147
P/E 8.53
Сайт http://www.modernatx.com
Число акций ао 0.382 млрд
Выручка 0.048
Див.доход ао 0
ISIN US60770K1079
Change price per day: -1.1073% (122.82)
Change price per week: +2.65% (118.32)
Change price per month: -17.78% (147.72)
Change price per 3 month: +15.52% (105.14)
Change price per half year: +14.64% (105.95)
Change price per year: -1.1154% (122.83)
Change price per 3 year: -64.82% (345.21)
Change price per 5 year: +76.85% (68.68)
Change price per year to date: +22.13% (99.45)


All parameters ⇨

Underestimation

Title Value Grade
P/S 130.09 2
P/BV 5.32 6
P/E 8.53 9
EV/EBITDA -11.94 0
Total:

Efficiency

Title Value Grade
ROA, % -21.29 0
ROE, % -28.59 0
Total:

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total:

Debt

Title Value Grade
Debt/EBITDA -0.3872 10
Total:

Growth impulse

Title Value Grade
Profit growth, % 104.74 10
Share price growth, % 84.58 10
Dividend growth, % 0 0
Total:

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
17.06.2024 18.06.2024 Hoge Stephen
President
Sale 138.16 2 072 400 15000 0 0 link
11.06.2024 11.06.2024 AFEYAN NOUBAR
Director
Sale 148.34 30 088 100 202832 0 -0.05 link
10.06.2024 11.06.2024 Klinger Shannon Thyme
Chief Legal Officer
Sale 148.09 766 810 5178 0 0 link
28.05.2024 29.05.2024 Klinger Shannon Thyme
Chief Legal Officer
Sale 162.47 210 561 1296 0 0 link
22.05.2024 24.05.2024 AFEYAN NOUBAR
Director
Sale 157.57 2 363 550 15000 0 0 link
15.05.2024 17.05.2024 AFEYAN NOUBAR
Director
Sale 127.32 1 909 800 15000 0 0 link
10.05.2024 13.05.2024 Hoge Stephen
President
Sale 120.96 30 845 255 0 0 link
08.05.2024 10.05.2024 AFEYAN NOUBAR
Director
Sale 121.68 1 825 200 15000 0 0 link
01.05.2024 03.05.2024 AFEYAN NOUBAR
Director
Sale 110.92 1 663 800 15000 0 0 link
24.04.2024 26.04.2024 AFEYAN NOUBAR
Director
Sale 108.32 1 624 800 15000 0 0 link
17.04.2024 19.04.2024 AFEYAN NOUBAR
Director
Sale 103.38 1 550 700 15000 0 0 link
15.04.2024 16.04.2024 Hoge Stephen
President
Sale 105.02 1 575 300 15000 0 0 link
10.04.2024 12.04.2024 AFEYAN NOUBAR
Director
Sale 107.12 1 606 800 15000 0 0 link
08.04.2024 09.04.2024 Mock James M
Chief Financial Officer
Sale 101.93 71 861 705 0 0 link
03.04.2024 05.04.2024 AFEYAN NOUBAR
Director
Sale 101.68 1 525 200 15000 0 0 link
27.03.2024 29.03.2024 AFEYAN NOUBAR
Director
Sale 109.06 1 635 900 15000 0 0 link
20.03.2024 22.03.2024 AFEYAN NOUBAR
Director
Sale 102.39 1 535 850 15000 0 0 link
13.03.2024 15.03.2024 AFEYAN NOUBAR
Director
Sale 108.54 1 628 100 15000 0 0 link
20.09.2023 22.09.2023 AFEYAN NOUBAR
Director
Sale 104.74 1 571 100 15000 0 0 link
15.09.2023 18.09.2023 Hoge Stephen
President
Sale 112.99 1 694 850 15000 0 0 link
08.09.2023 11.09.2023 Klinger Shannon Thyme
Chief Legal Officer
Sale 107.22 59 722 557 0 0 link
06.09.2023 08.09.2023 AFEYAN NOUBAR
Director
Sale 107.61 1 614 150 15000 0 0 link
30.08.2023 01.09.2023 AFEYAN NOUBAR
Director
Sale 115.46 1 731 900 15000 0 0 link
23.08.2023 25.08.2023 AFEYAN NOUBAR
Director
Sale 115.51 1 732 650 15000 0 0 link
16.08.2023 18.08.2023 AFEYAN NOUBAR
Director
Sale 97.56 975 600 10000 0 0 link
02.08.2023 04.08.2023 AFEYAN NOUBAR
Director
Sale 110.99 1 664 850 15000 0 0 link
26.07.2023 28.07.2023 AFEYAN NOUBAR
Director
Sale 120.42 1 806 300 15000 0 0 link
19.07.2023 21.07.2023 AFEYAN NOUBAR
Director
Sale 125.48 1 882 200 15000 0 0 link
12.07.2023 14.07.2023 AFEYAN NOUBAR
Director
Sale 125.81 1 887 150 15000 0 0 link
05.07.2023 07.07.2023 AFEYAN NOUBAR
Director
Sale 124.73 1 870 950 15000 0 0 link
28.06.2023 30.06.2023 AFEYAN NOUBAR
Director
Sale 121.54 1 823 100 15000 0 0 link
21.06.2023 23.06.2023 AFEYAN NOUBAR
Director
Sale 121.95 1 829 250 15000 0 0 link
07.06.2023 09.06.2023 AFEYAN NOUBAR
Director
Sale 125.91 1 888 650 15000 0 0 link
31.05.2023 02.06.2023 AFEYAN NOUBAR
Director
Sale 127.35 1 910 250 15000 0 0 link
20.04.2023 21.04.2023 Bancel Stephane
Chief Executive Officer
Sale 142.99 5 719 600 40000 0 -0.01 link
20.04.2023 21.04.2023 Bancel Stephane
Chief Executive Officer
Purchase 0.99 39 600 40000 0 0.01 link
19.04.2023 21.04.2023 Bancel Stephane
Chief Executive Officer
Sale 142.88 5 715 200 40000 0 -0.01 link
19.04.2023 21.04.2023 Bancel Stephane
Chief Executive Officer
Purchase 0.99 39 600 40000 0 0.01 link
18.01.2023 20.01.2023 AFEYAN NOUBAR
Director
Sale 200.2 2 002 000 10000 0 0 link
11.01.2023 13.01.2023 AFEYAN NOUBAR
Director
Sale 188.57 1 885 700 10000 0 0 link
21.12.2022 23.12.2022 AFEYAN NOUBAR
Director
Sale 201.7 2 017 000 10000 0 0 link
21.12.2022 23.12.2022 Andres Juan
See remarks
Sale 201.7 403 400 2000 0 0 link
21.12.2022 23.12.2022 Andres Juan
See remarks
Purchase 20.93 41 860 2000 0 0 link
23.11.2022 25.11.2022 AFEYAN NOUBAR
Director
Sale 178.01 1 780 100 10000 0 0 link
02.11.2022 04.11.2022 AFEYAN NOUBAR
Director
Sale 154.2 1 542 000 10000 0 0 link
26.10.2022 28.10.2022 AFEYAN NOUBAR
Director
Sale 137.25 1 372 500 10000 0 0 link
19.10.2022 21.10.2022 AFEYAN NOUBAR
Director
Sale 132.5 1 325 000 10000 0 0 link
12.10.2022 14.10.2022 AFEYAN NOUBAR
Director
Sale 135.36 1 353 600 10000 0 0 link
05.10.2022 07.10.2022 AFEYAN NOUBAR
Director
Sale 122.4 1 224 000 10000 0 0 link
28.09.2022 30.09.2022 AFEYAN NOUBAR
Director
Sale 123.58 1 235 800 10000 0 0 link
21.09.2022 23.09.2022 AFEYAN NOUBAR
Director
Sale 130.37 1 303 700 10000 0 0 link
14.09.2022 16.09.2022 AFEYAN NOUBAR
Director
Sale 134 1 340 000 10000 0 0 link
07.09.2022 09.09.2022 AFEYAN NOUBAR
Director
Sale 129.68 1 296 800 10000 0 0 link
31.08.2022 02.09.2022 AFEYAN NOUBAR
Director
Sale 136.95 1 369 500 10000 0 0 link
17.08.2022 19.08.2022 AFEYAN NOUBAR
Director
Sale 165.24 1 652 400 10000 0 0 link
10.08.2022 12.08.2022 AFEYAN NOUBAR
Director
Sale 174.09 1 740 900 10000 0 0 link
10.08.2022 11.08.2022 Hoge Stephen
President
Sale 173.66 42 373 244 0 0 link
09.08.2022 11.08.2022 Hoge Stephen
President
Purchase 171.81 89 685 522 0 0 link
03.08.2022 05.08.2022 AFEYAN NOUBAR
Director
Sale 167.99 1 679 900 10000 0 0 link
27.07.2022 29.07.2022 AFEYAN NOUBAR
Director
Sale 161 1 610 000 10000 0 0 link
25.07.2022 26.07.2022 Hoge Stephen
President
Sale 162.75 1 627 500 10000 0 0 link
20.07.2022 22.07.2022 AFEYAN NOUBAR
Director
Sale 167 1 670 000 10000 0 0 link
13.07.2022 15.07.2022 AFEYAN NOUBAR
Director
Sale 168.88 1 688 800 10000 0 0 link
06.07.2022 08.07.2022 AFEYAN NOUBAR
Director
Sale 154.85 1 548 500 10000 0 0 link
29.06.2022 01.07.2022 AFEYAN NOUBAR
Director
Sale 140.47 1 404 700 10000 0 0 link
24.06.2022 27.06.2022 Hoge Stephen
President
Sale 143.98 719 900 5000 0 0 link
24.06.2022 27.06.2022 Hoge Stephen
President
Purchase 10.9 54 500 5000 0 0 link
23.06.2022 27.06.2022 Hoge Stephen
President
Sale 135.96 679 800 5000 0 0 link
23.06.2022 27.06.2022 Hoge Stephen
President
Purchase 10.9 54 500 5000 0 0 link
22.06.2022 24.06.2022 AFEYAN NOUBAR
Director
Sale 127.69 1 276 900 10000 0 0 link
08.06.2022 10.06.2022 AFEYAN NOUBAR
Director
Sale 147.47 1 474 700 10000 0 0 link
25.05.2022 27.05.2022 AFEYAN NOUBAR
Director
Sale 130.8 1 308 000 10000 0 0 link
18.05.2022 20.05.2022 AFEYAN NOUBAR
Director
Sale 138.38 1 383 800 10000 0 0 link
14.04.2022 15.04.2022 Bancel Stephane
Chief Executive Officer
Sale 168.59 1 685 900 10000 0 0 link
13.04.2022 15.04.2022 Andres Juan
See remarks
Sale 158.37 316 740 2000 0 0 link
13.04.2022 15.04.2022 Andres Juan
See remarks
Purchase 14.22 28 440 2000 0 0 link
13.04.2022 15.04.2022 Bancel Stephane
Chief Executive Officer
Sale 170.26 1 532 340 9000 0 0 link
03.02.2022 04.02.2022 Bancel Stephane
Chief Executive Officer
Sale 165 1 650 000 10000 0 0 link
02.02.2022 04.02.2022 Bancel Stephane
Chief Executive Officer
Sale 170.89 1 538 010 9000 0 0 link
24.01.2022 25.01.2022 Hoge Stephen
President
Sale 150.67 3 013 400 20000 0 0 link
24.01.2022 25.01.2022 Hoge Stephen
President
Purchase 5.95 119 000 20000 0 0 link
20.01.2022 21.01.2022 Bancel Stephane
Chief Executive Officer
Sale 175.01 1 750 100 10000 0 0 link
19.01.2022 21.01.2022 Bancel Stephane
Chief Executive Officer
Sale 188.55 1 696 950 9000 0 0 link
22.11.2021 23.11.2021 Andres Juan
See remarks
Sale 268.18 4 022 700 15000 0 0 link
22.11.2021 23.11.2021 Andres Juan
See remarks
Purchase 13.55 203 250 15000 0 0 link
19.11.2021 23.11.2021 Andres Juan
See remarks
Sale 265.71 1 328 550 5000 0 0 link
19.11.2021 23.11.2021 Andres Juan
See remarks
Purchase 12.21 61 050 5000 0 0 link
16.06.2021 21.06.2021 Zaks Tal Zvi
Chief Medical Officer
Sale 200 1 000 000 5000 0 0 link
16.06.2021 21.06.2021 Zaks Tal Zvi
Chief Medical Officer
Purchase 25.93 129 650 5000 0 0 link
31.03.2021 31.03.2021 AFEYAN NOUBAR
Director
Sale 121.07 591 790 4888 0 0 link
30.03.2021 31.03.2021 AFEYAN NOUBAR
Director
Sale 118.97 251 359 000 2112795 0 -0.64 link
29.03.2021 31.03.2021 AFEYAN NOUBAR
Director
Sale 124.6 203 736 000 1635122 0 -0.5 link
23.03.2021 25.03.2021 HENDERSON LORI M.
General Counsel and Secretary
Sale 145.55 960 630 6600 0 0 link
23.03.2021 25.03.2021 HENDERSON LORI M.
General Counsel and Secretary
Purchase 20.93 138 138 6600 0 0 link

Institutions Volume Share, %
Baillie Gifford and Company 45654527 11.92
Vanguard Group Inc 33907072 8.86
Blackrock Inc. 25301692 6.61
State Street Corporation 14623723 3.82
Flagship Pioneering Inc. 9666038 2.52
Theleme Partners LLP 7349456 1.92
Wellington Management Group, LLP 7225579 1.89
Geode Capital Management, LLC 6549461 1.71
FMR, LLC 6393351 1.67
Goldman Sachs Group Inc 4551626 1.19

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Morningstar Mid-Cap Growth ETF 1.64 85.13 0.09
AGFiQ US Market Neutral Momentum Fund 0.71 -16.42 2.58
iShares Russell 1000 Pure U.S. Revenue ETF 1.15 35.03 1.87
Collaborative Investment Series Trust Trend Aggregation US Fund 1.38 4.03 20.07
Nationwide Maximum Diversification U.S. Core Equity ETF 1.6 26.65 1.58
Apex Healthcare ETF 4.49
iShares Evolved U.S. Innovative Healthcare ETF 4.38 27.98 2.79
Direxion mRNA ETF 5.95
FinEx USA UCITS ETF 0.08 54.54
Invesco ESG S&P 500 Equal Weight ETF 0.6 1.79
Amplify Treatments Testing and Advancements ETF 8.85 71.57 1.06
iShares Exponential Technologies ETF 0.81 33.42 0.45
First Trust Nasdaq-100 Equal Weighted Index Fund 1.25 30.52 0.69
ARK Genomic Revolution ETF 3.51 41.63
Direxion NASDAQ-100 Equal Weighted Index Shares 1.25 30.67 0.85
Invesco S&P 500 Equal Weight Health Care ETF 2.11 0.64
iShares Morningstar Mid-Cap Value ETF 0.88 47.17 2.28
VanEck Biotech ETF 6.96 38.53 0.43
Amplify Etho Climate Leadership U.S. ETF 0.47 38.41 1.35
iShares Genomics Immunology and Healthcare ETF 6.39 43.41 1.21
First Trust Nasdaq-100 Ex-Technology Sector Index Fund 2.15 28.29 1.17
Global X Genomics & Biotechnology ETF 4.88 39.55
ProShares Ultra Nasdaq Biotechnology 3.52 57.51 0.14
ROBO Global Healthcare Technology and Innovation ETF 2.55 43.56
Invesco Nasdaq Biotechnology ETF 5.32 0.82
Principal Healthcare Innovators ETF 4.24 32.51
Vanguard Mid-Cap Growth ETF 1.43 34.33 0.69
iShares Biotechnology ETF 4.59 31.10 0.29
SPDR S&P Biotech ETF 2.59 23.57 0.14
Vanguard Mid-Cap ETF 0.65 38.30 1.61
First Trust NYSE Arca Biotechnology Index Fund 3.56 11.39



Head Job title Payment Year of birth
Mr. Stephane Bancel CEO & Director 4.55M 1973 (51 year)
Ms. Lavina Talukdar CFA Senior VP & Head of Investor Relations N/A
Ms. Shannon Thyme Klinger Chief Legal Officer & Corporate Secretary 1.39M 1971 (53 years)
Dr. Stephen Hoge M.D. President 1.92M 1977 (47 years)
Mr. James M. Mock Chief Financial Officer 1.4M 1977 (47 years)
Dr. Jerh Collins Ph.D. Chief Technical Operations & Quality Officer N/A 1967 (57 years)
Mr. Brad Miller Chief Information Officer N/A 1974 (50 years)
Colleen Hussey Senior Director of Corporate Communications N/A
Ms. Tracey Franklin Chief Human Resources Officer N/A 1981 (43 years)
Dr. Melanie Ivarsson M.B.A., Ph.D. Chief Development Officer N/A

Address: United States, Cambridge, MA , 200 Technology Square - open in Google maps, open in Yandex maps
Website: http://www.modernatx.com